Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues

被引:0
作者
Suhara, Y
Takayama, H
Nakane, S
Miyashita, T
Waku, K
Sugiura, T [1 ]
机构
[1] Teikyo Univ, Fac Pharmaceut Sci, Dept Hyg Chem & Nutr, Kanagawa 1990195, Japan
[2] Teikyo Univ, Fac Pharmaceut Sci, Dept Pharmaceut Chem, Kanagawa 1990195, Japan
关键词
cannabinoid; 2-arachidonoylglycerol; anandamide; Delta(9)-tetrahydrocannabinol; monoacylglycerol; ether-linked analogue;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We synthesized 2-arachidonoylglycerol (1), an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues. Compound 1 was synthesized from 1,3-benzylideneglycerol (6) and arachidonic acid in the presence of N,N'-dicyclohexylcarbodiimide and 4-dimethylaminopyridine followed by treatment with boric acid and trimethyl berate. An ether-linked analogue of 2-arachidonoylglycerol (2) nas synthesized from 6 and 5,8,11,14-eicosatetraenyl iodide (9). The ether-linked analogues of 2-palmitoylglycerol (4) and 2-oleoyglycerol (5) were synthesized from 6 and hexadecyl iodide (12) and 9-octadecenyl iodide (14), respectively. We confirmed that 1 stimulates NG108-15 cells to induce rapid transient elevation of the intracellular free Ca2+ concentrations through a CB1 receptor-dependent mechanism. Noticeably; 2 exhibited appreciable agonistic activity; although its activity was significantly lower than that of 1. Compound 2 would be a useful tool in exploring the physiological significance of 1, because this compound is resistant to hydrolyzing enzymes in contrast to 1. On the other hand, the ether-linked analogues of either 4 or 5 failed to act as a CB1 receptor agonist. Compounds 4 and 5 would also be valuable as control molecules in experiments where 2 is employed.
引用
收藏
页码:903 / 907
页数:5
相关论文
共 20 条
[1]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605
[2]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[3]  
DEWEY WL, 1986, PHARMACOL REV, V38, P151
[4]   'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance [J].
Di Marzo, V .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1998, 1392 (2-3) :153-175
[5]  
Di Marzo V, 1998, BIOCHEM J, V331, P15
[6]   Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action [J].
Di Marzo, V ;
Melck, D ;
Bisogno, T ;
De Petrocellis, L .
TRENDS IN NEUROSCIENCES, 1998, 21 (12) :521-528
[7]   Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand [J].
Goparaju, SK ;
Ueda, N ;
Yamaguchi, H ;
Yamamoto, S .
FEBS LETTERS, 1998, 422 (01) :69-73
[8]   Total synthesis of 2-Arachidonylglycerol (2-Ara-Gl) [J].
Han, LN ;
Razdan, RK .
TETRAHEDRON LETTERS, 1999, 40 (09) :1631-1634
[9]  
LEE M, 1995, J PHARMACOL EXP THER, V275, P529
[10]   PREPARATION OF SATURATED AND UNSATURATED SYMMETRICAL MONOGLYCERIDES [J].
MARTIN, JB .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1953, 75 (22) :5482-5483